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Expansion and activation of CD4+CD25+ regulatory
T cells in Heligmosomoides polygyrus infection
Constance A. M. Finney, Matthew D. Taylor, Mark S. Wilson* and
Rick M. Maizels
Institute of Immunology and Infection Research, University of Edinburgh,
Edinburgh, UK
Regulatory T cell responses to infectious organisms influence not only immunity and
immunopathology, but also responses to bystander antigens. Mice infected with the
gastrointestinal nematode parasite Heligmosomoides polygyrus show an early Th2-
dominated immune response (days 7–14), but by day 28 a strongly regulatory profile is
evident with antigen-specific IL-10 release and elevated frequency of CD4+ T cells
bearing surface TGF-b. CD4+CD25+ Tcells from infected mice show enhanced capacity
to block in vitro effector T cell proliferation. CD4+CD25+ cell numbers expand
dramatically during infection, with parallel growth of both CD25+Foxp3+ and
CD25+Foxp3– subsets. CTLA-4 and glucocorticoid-induced tolerance-associated
receptor, also associated with regulatory T cell function, become more prominent,
due to both expanded CD25+ cell numbers and increased expression among the CD25–
population. Both intensity and frequency of CD103 expression by CD4+ T cells rise
significantly, with greatest expansion among CD25+Foxp3+ cells. While TGF-b
expression is observed among both CD25+Foxp3+ and CD25+Foxp3– subsets, it is
the latter populationwhich shows higher TGF-b staining following infection. These data
demonstrate in a chronic helminth infection that Foxp3+ regulatory T cells are
stimulated, increasing CD103 expression in particular, but that significant changes
occur to other populations including expansion of CD25+TGF-b+Foxp3– cells, and
induction of CTLA-4 on CD25– non-regulatory lymphocytes.
Introduction
Long-lived helminth parasite infections develop an
intriguing balance with the immune system of their
host [1, 2]. Their continued survival in an immuno-
logically sufficient environment may be ascribed in part
to interference with immune activation and attack [3,
4]. However, there is increasing evidence that the
infected host develops a form of immunological
'tolerance' to parasite antigens, which may selectively
mute certain effector mechanisms [5]. The possibility
that susceptibility to helminth infections may be
mediated, in part, by regulatory T cells (Treg) is
supported by recent work showing that antibody
treatment to Treg markers results in heightened anti-
parasite responsiveness and clearance of adult worms in
Litosomosoides sigmodontis infection [6].
Immunological down-modulation during infection is
also important in protecting the host from the more
pathological outcomes of infection. In the case of
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schistosomiasis, egg production can cause hepatic
granulomatous disease in chronically infected hosts
[7]. Immunopathology is controlled initially by the
regulatory cytokine IL-10, as IL-10-deficient mice
succumb to acute liver inflammation [8], while chronic
granulomatous fibrosis can be suppressed by T cells
transfected with the forkhead box transcription
factor p3 (Foxp3) [9], which is functionally associated
with Treg activity [10, 11].
The ability of helminth infection to modulate
responses to unrelated bystander antigens is well
established [12, 13]. More recently, it has been
recognised that infection can alter the pathological
outcome of autoimmune [14, 15] and allergic [16]
challenge. Indeed, we recently showed that infection
with the murine gastrointestinal nematode Heligmoso-
moides polygyrus dampens immune responsiveness to
unrelated allergens (ovalbumin and the house dust mite
antigen Der p1) in a manner dependent upon
CD4+CD25+ T cell activity, but independent of the
action of IL-10 [17]. Moreover, CD4+CD25+ Tcells from
the mesenteric lymph nodes (MLN) of H. polygyrus-
infected, allergen-nave mice were able to confer
suppression of allergy when transferred to uninfected,
allergen-sensitized recipients, demonstrating their po-
tent regulatory capacity [17].
Two cardinal characteristics associated with human
helminthiases are reproduced in the H. polygyrusmodel
of infection. First, this parasite is known to induce a
dominant Th2 response [18–23], while secondly it
provides an excellent example of generalised down-
regulation of immune responsiveness [24–26], attribu-
table in part to the activity of CD4+CD25+ Treg [17]. In
the present study, we follow in detail the evolution of
both Th2 and Treg parameters over the course of
infection, with particular focus on CTLA-4 (CD152),
glucocorticoid-induced tolerance-associated receptor
(GITR), CD103, TGF-b and Foxp3 within both
CD4+CD25+ and CD4+CD25– subsets, as well as the
functional characteristics of Treg populations.
Results
H. polygyrus generates a typical Th2 response
early in infection
H. polygyrus is a natural gastrointestinal nematode
parasite of mice, which follows a direct transmission
cycle [27]. Orally ingested larvae invade the intestinal
mucosa, from where, 9–11 days post-infection, they
emerge as adult worms [28]. Subsequently, in most
strains of mice, they survive as chronic, luminal-
dwelling infections that may persist for as long as
300 days [29].
To analyse the adaptive immune response to
H. polygyrus, we first characterised the cytokine profile
of MLN and spleen cells in response to parasite antigen
challenge in vitro, over the course of a 10-wk infection.
As shown in Fig. 1, by day 7 there is a substantial Th2-
type response marked by antigen-specific IL-4, IL-5, IL-9
and IL-13 evident in the MLN. Th2 responsiveness
remains for the life of the infection although generally
down-modulated after day 21. Splenic responses are
slower to evolve but follow a similar pattern of Th2
responsiveness, as previously reported [18–23].
In contrast, Th1-type responses are relatively feeble.
As shown in Fig. 2A, parasite-specific IFN-c responses in
vitro are only detectable at day 70, when infection is
Figure 1. Elevated Th2 cytokine responsiveness in H. polygyrus
infection. Parasite antigen-specific cytokine responses are
presented from MLNC (left) and spleen cells (right) taken at
day 7–70 post-infection. Cells were cultured for 48 h in
medium alone (open symbols) or H. polygyrus antigen (solid
symbols). Panels (A–D) present respectively IL-4, IL-5, IL-9 and
IL-13. Data represent means  SE from groups of five mice
assayed individually; day 0 represents all nave mice (five for
each time point).
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waning. A nascent Th1 reaction at day 7 can be detected
at the mRNA level, evident by raised T-box family
transcription factor expressed in T cells (T-BET)
expression in RT-PCR (Fig. 2B), at the stage when
larval parasites are still resident in the intestinal mucosa.
However, by day 28, when adult worms are established
in the gut lumen, this T-BET has been replaced by the
Th2-promoting factor GATA-3 (Fig. 2B). A further
reflection of Th2 polarisation is in the isotype balance
of anti-H. polygyrus serum antibodies. As previously
reported [30], infection stimulates high levels of IgG1,
but no detectable IgG2a (Fig. 2C).
Regulatory cytokine expression
MLN cells (MLNC) from H. polygyrus mice respond
briskly to parasite antigen challenge in vitro with IL-10
release over the course of infection (Fig. 2B). Moreover,
ex vivo staining of MLNC from day 28-infected mice
shows significant increases in both intracellular IL-10
and surface-bound TGF-b (Fig. 2D). These findings are
consistent with other reports of elevated antigen-
specific and serum TGF-b in mice infected with
H. polygyrus [31].
Expansion of CD25+ T cells during infection
Expression of the IL-2Ra chain, CD25, is a widely used
but not exclusive marker for Treg [32]. Using flow
cytometry, we found that total CD4+CD25+ cell
numbers expand dramatically in the draining MLN
(Fig. 3A), although total LN cell counts are expanding
during the same period. A smaller rise in CD25+ cells
occurs in the spleen, particularly from day 21 onwards
(data not shown). The intensity of CD25 expression on
positive cells does not alter appreciably (Fig. 3B). When
considered as a proportion, it can be seen that
CD4+CD25+ cells outgrow CD4+CD25– cells from
day 7 onwards and remain in significant excess over
uninfected controls throughout infection (Fig. 4C).
In vitro suppressive activity by CD25+ Treg
A common test of functional Treg activity is their ability
to block the proliferative response of effector T cells to
antigen or mitogen stimulation [33]. We accordingly
assessed whether sorted CD4+CD25+ MLNC from
infected animals were able to suppress the proliferation
of CFSE-loaded nave, CD4+CD25– MLNC, responding
to Con A. We observed that, on a per-cell basis,
CD4+CD25+ MLNC, taken 28 day post-infection, were
substantially more suppressive than cells with similar
phenotype from nave animals (Fig. 4A, B).
In parallel experiments we also noted that
CD4+CD25– T cells from infected mice showed greater
resistance to proliferative inhibition, and indeed were
largely refractory to suppression by CD4+CD25+ MLNC
from nave mice (Fig. 4C). However, CD4+CD25–
Figure 2.Nascent Th1 and sustained regulatory cytokine responses inH. polygyrus infection. (A) IFN-c and IL-10 release fromMLNC
directly stimulated ex vivo, taken at days 7–70 post-infection and cultured for 48 h inmediumalone (open symbols) orH. polygyrus
antigen (solid symbols). (B) T-BETand GATA-3 real-time PCR inMLN fromnave and infectedmice. CD4+ T cells were purified from
MLN, RNAwas extracted and real-time PCR performed on the resulting cDNA. (C) H. polygyrus-specific serum antibodies of IgG1
and IgG2a isotypesmeasured by ELISA. (D) Intracellular IL-10 (left) and surface TGF-b (right) staining in nave and day 28-infected
MLN CD4+ T cells determined by flow cytometry. Data represent means  SE from groups of five mice assayed individually; day 0
represents all nave mice (five for each time point). *p < 0.05, **p < 0.01.
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effectors from H. polygyrus-infected animals remained
susceptible to inhibition by the more 'activated'
regulatory cells from infected mice (Fig. 4D, E).
Foxp3 expression levels remain relatively
constant during infection
A key marker for natural Treg is the transcription factor
Foxp3, which is expressed by the majority of CD25+
T cells [10, 11, 34]. As previously reported [17], we
found that H. polygyrus infection results in a modest
increase in CD4+CD25+Foxp3+ cells (from 7.4% of all
CD4+ cells at day 0 to 9.7% at day 28; Fig. 5A).
Expansion occurs rapidly following infection (Fig. 5B),
although, due to parallel expansion of CD25+Foxp3–
cells in infection, there is in fact a small diminution in
the proportion of CD4+CD25+ cells which express
Foxp3 (Fig. 5C). It was also apparent that the intensity of
Foxp3 expression within the Foxp3+CD4+CD25+ T cell
population does not increase (Fig. 5D). Thus, the
increment in CD25+ cells during infection is not
accompanied by preferential Foxp3 induction and
represents an expansion of both CD4+CD25+Foxp3+
and CD4+CD25+Foxp3– T cells. This latter phenotype
may represent either an activated effector cell (which
could be stimulated in the environment of chronic
infection), or a Foxp3– 'adaptive' or inducible Treg.
Increased frequency of CTLA-4 and GITR
expression during infection
Two surface markers closely associated with the Treg
phenotype are CTLA-4 [35] and GITR [36]. Both were
measured in MLN and spleen cells over the 70-day time
course. At day 28, for example, CTLA-4 is expressed by
23% of CD4+ Tcells, compared to 12% in nave controls
(Fig. 6A). This increase is represented by a relatively
constant per-cell level within the CD4+CD25+ popula-
tion, together with a significant rise in expression among
CD4+CD25– cells (Fig. 6A). Moreover, within the
CD4+CD25+ compartment (Fig. 6B) CTLA-4 staining
increases more than twofold among the Foxp3– subset,
while actually declining in Foxp3+ cells. A similar,
though less marked, trend is seen with GITR staining;
overall GITR expression within the CD4+ T cell popula-
tion rises from 8.5% in naves to 13.8% in day 28-
infected mice (Fig. 6C). Again there is a significant rise
in the proportion of CD4+CD25– cells expressing GITR,
and within the CD4+CD25+ subset the expansion in
GITR+ cells occurs with the Foxp3– population (Fig. 6D).
These changes are sustained over the longer term course
of infection (Fig. 6E, F). Thus, the uplift in CTLA-4 and
GITR is observed primarily, if not totally, within cells of a
non-regulatory phenotype.
CD103 and TGF-b expression is raised in
frequency and intensity by infection
We also examined expression of CD103 (the
integrin aEb7) and of the regulatory cytokine TGF-b
in the CD4+ populations. In the MLN, there were
significant increases in the proportion of CD4+CD25+
T cells which express CD103, returning to control levels
by day 70 of infection (Fig. 7A); a similar pattern was
observed in splenic populations (data not shown). While
most CD103-expressing cells were in the CD4+CD25+
Figure 3. Expansion of CD25-expressing cells within the total CD4+ T cell population during H. polygyrus infection. (A) Total
numbers of CD4+CD25+ T cells fromday 7–70 post-infection inMLN. (B) Representative histograms of CD25 expressionwithinMLN
(left) or splenic (right) CD4+ cells from day 28-infected (black) or nave (grey) mice; isotype controls are shown as thick black lines.
(C) Changes in proportion of CD25-expressing CD4+ T cells relative to total CD4+ cells over 70 days of infection. For each point in
time, the percentages of CD4+ T cellswhich also expressed CD25 amongMLNC from infected and nave animalswere determined;
the arithmetic difference between infected and nave in percentage frequency at each time point was then calculated. The mean
nave level was 14.36% (SD = 0.80). For (A, C), Mann–Whitney tests were performed (n.s., no significant difference; *p<0.05,
**p<0.01). Data represent means  SE from groups of five mice assayed individually, comparedwith nave mice at the same assay
time. Day 0 represents all nave mice (five for each time point).
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subset, there were also small but significant increases in
the frequency of CD103+ among CD25– cells. Moreover,
infection induced a substantial upshift in intensity of
CD103 expression, reaching levels approximately 50%
higher than in nave populations (Fig. 7B).
A similar profile was observed for surface-bound
TGF-b. A modest, but significant, rise in TGF-b staining
occurred in both MLN and splenocytes, peaking at
day 21–28; thus by day 28 nearly 10% of all
CD4+CD25+ T cells were TGF-b+, although no change
was seen in the very low levels of TGF-b among
CD4+CD25– cells (Fig. 7C). There was also a measurable
rise in fluorescence intensity, evident only in the
CD4+CD25+ population, over the first 28 days of
infection (Fig. 7D).
CD25+Foxp3+ cells express higher CD103, and
CD25+Foxp3– cells show raised TGF-b expression
Since the CD4+CD25+ population from infected mice
displayed increases in both CD103 and TGF-b, co-
staining was performed for these markers and for the
Foxp3 transcription factor. These analyses showed,
firstly, that in nave MLNC approximately two-thirds
of the CD103+ cells are Foxp3+ (Fig. 8A), as are a similar
proportion of the TGF-b+ cells (Fig. 8B). However,
infection generated a substantial and significant in-
crease in CD25+CD103+Foxp3+ cells (Fig. 8A), while
the frequency of TGF-b+Foxp3+ cells did not differ
between nave and infected mice (Fig. 8B). Moreover,
we found that both CD103 and TGF-b staining occurs on
a significant subset of CD25+Foxp3– cells, and indeed
comparison of nave and infected MLN shows significant
increases in CD103+Foxp3– (Fig. 8A) and in
TGF-b+Foxp3– cells (Fig. 8B).
Discussion
It is now evident that Treg are active at many points in
the control of immune responses against pathogens
[37–41]. CD4+CD25+ Treg block protective immunity in
animal models of malaria [42] and filariasis [6], but are
also required to minimise pathology caused by the
response to pathogen invasion [43–45]. This critical
balance between benefit and harm is played out against
a backdrop of pathogens which are likely to have evolved
strategies to favour Treg priming, recruitment and
survival [41]. For the host, the optimal regulatory
response may permit residual parasite survival, so
providing ongoing antigenic stimulation without disease
[38]. Thus, whether considering susceptibility, pathol-
ogy or immunity to pathogens, the contribution of Treg
populations can prove decisive.
Helminth parasitic diseases are typically slowly
evolving and chronic in nature, often associated with
immune down-regulation [1, 5]. Evidence from human
lymphatic filariasis, onchocerciasis and schistosomiasis
records a down-modulation of immunity which is
consistent with the activity of Treg-like cells, involving
IL-10, TGF-b and CTLA-4 [1, 46–49]. In animal models
of filariasis [50] and schistosomiasis [51, 52], Treg
phenotype populations develop following infection,
Figure 4. CD4+CD25+ T cells from H. polygyrus-infected mice
showmore potent suppression of CD25– effector cell prolifera-
tion. Proliferation of 5104 CD4+CD25– T cells in response to in
vitro Con A stimulation was measured by CFSE (grey lines), in
populations fromnave (A, B) and day 28-infected (C, D) MLNC.
In parallel cultures, equal numbers of CD4+CD25+ MLNC were
added to the CD4+CD25– CFSE-loaded T cells. MLNC from
infected mice (B, D; black lines) show more profound suppres-
sion than equal numbers of cells from uninfected controls
(A, C; black lines). Tables beneath each graph give percentage
of CD25– cells in each round of division when stimulated in the
absence (upper row) or presence (lower row) of CD25+ cells.
Data represent pooled cells from groups of five mice.
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whilst in infection with the murine gastrointestinal
nematode H. polygyrus [17], functional regulation by
CD4+CD25+ T cells suppresses the bystander response
to an allergic provocation. In the current study, we also
show that this phenotype is enhanced, following
infection, in its ability to suppress the polyclonal
proliferative response of CD25– effector cells. However,
the origin and specificity of the CD4+C25+ population
generated by this or other helminth infections have yet
to be delineated.
CD25 (IL-2Ra) is not a unique marker for Treg, being
also expressed on activated effector T cells [33]. For this
reason we analysed additional functional and pheno-
typic markers, including the transcription factor Foxp3
[10] and the inhibitory/stimulatory co-receptors
CTLA-4 [35] and GITR [36, 53]. Expression of Foxp3,
as well as the production of the suppressive cytokines
IL-10 and TGF-b, are considered to distinguish natural or
adaptive Treg subsets [54].
Broadly, natural Treg arise during the normal process
of maturation in the thymus, are selected on the basis of
specificity for self antigens, express surface CD25 and
Foxp3, and employ cell contact-dependent suppressive
mechanisms. In contrast, adaptive Treg are thought to
develop from nave (CD25–, Th0) mature peripheral
populations in response to specific stimulatory condi-
tions such as sub-optimal signalling from accessory cells.
Adaptive Treg include those designated Tr1 [55] and
Th3 [56], produce IL-10 or TGF-b, and have induced
CD25 expression. Whether these cells also initiate Foxp3
expression is controversial. No induction could be found
either in Tr1 induced in vitro with IL-10, or in vivo by
intranasal tolerisation [57]. However, in vitro
CD4+CD25– T cells can be induced to express CD25
and Foxp3 following stimulation with TGF-b [58–60],
and in a T cell receptor-transgenic, thymectomised
mouse, de novo Foxp3 expression was induced in a
regulatory CD25+ population exposed to low-dose
Figure 5. CD4+ T cell Foxp3 expression levels remain relatively constant duringH. polygyrus infection. (A) Bivariate flow cytometry
analysis of CD25 and Foxp3 expression in CD4+ T cells in nave (far left), day 7-infected (left) and nave (right) and day 28-infected
(far right)MLNC. (B) Time course of expression of CD25+Foxp3+ as percentage of total CD4+ cells inMLN from7–70 days of infection.
Themeannave levelwas 6.43% (SD = 2.27). (C) Foxp3+ T cells as proportion of total CD4+CD25+ T cells in nave and day 28-infected
MLN. The mean nave level was 67.2% (SD = 17.1). (D) Foxp3 expression intensity over the course of infection. The percentage
difference in MFI relative to uninfected values for Foxp3 was calculated. For (B–D) data represent means  SE from groups of five
mice assayed individually; day 0 represents all navemice (five for each time point). Mann–Whitney testswere performed (n.s., no
significant difference; *p<0.05, **p<0.01).
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Figure 6. CTLA-4 and GITR expression levels increase on CD4+CD25– cells, but not on CD4+CD25+ cells, during H. polygyrus
infection. (A) CTLA-4 expression measured by flow cytometry on MLNC. (Left panels) CTLA-4 and CD25 bivariate plot from nave
and day 28-infected mice; (right panels) percentage of CTLA-4high T cells in the CD4+CD25+ and CD4+CD25– subsets. (B) CTLA-4
expression measured by flow cytometry on MLNC. (Left panels) CTLA-4 and Foxp3 bivariate plot from nave and day 28-infected
mice; (right panels) percentage of CTLA-4high T cells in the CD25+Foxp3+ and CD25+Foxp3– subsets. (C) GITR expression, measured
as for CTLA-4 in Fig. 7A. (D) GITR expression, measured as for CTLA-4 in Fig. 7B. (E) Frequency of CTLA-4 expression in CD4+CD25–
cells over the course of infection. Mean nave level = 6.58% (SD = 1.82). (F) Frequency of GITR expression in CD4+CD25– cells over
the course of infection. Mean nave level = 5.45% (SD = 4.75). Data represent means  SE from groups of five mice assayed
individually. Mann–Whitney tests were performed (n.s., no significant difference; *p<0.05, **p<0.01, ***p<0.001.
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antigen delivered by osmotic pump [61]. Hence, Foxp3
expression delimits a subset containing all naturally
arising Treg and, possibly, a proportion of adaptive Treg.
In H. polygyrus infection, there is a preferential
expansion of CD25-expressing cells without a propor-
tional increase in Foxp3+ cells, and yet the functional
regulatory activity of the CD25+ T cell population is
greatly amplified in infected mice. Hence, the increment
in CD25+Foxp3– T cell numbers is unlikely to represent
effector cell expansion alone. A plausible hypothesis is
that many of the CD25+Foxp3– cells are adaptive Treg,
with specificity for parasite antigens, which have arisen
from nave precursors with induction of expression of
CD25 rather than that of Foxp3. In addition, there is
good evidence from our work and that of others, that
production of IL-10 and TGF-b is substantially heigh-
tened in H. polygyrus infection [17, 31].
Treg-derived IL-10 is a major determinant in systems
where Th1 immune responses are protective, such as
murine infection with Leishmania major [38]. In
schistosome infections which drive dominant type-2
responsiveness, however, only a small proportion of the
IL-10 emanates from CD25+Foxp3+ Tcells [51, 52], and
even though IL-10 is important in the overall control of
immune pathology in schistosomiasis, granuloma mod-
ulation is IL-10-independent [8]. Moreover, IL-10 is a
critical promoter of strong Th2 responses in many
helminth systems [62], and unlike the Th1 setting does
not fulfil a purely down-regulatory role. This is
confirmed in the case of H. polygyrus, as the ability of
CD25+ Treg to suppress airway allergy in infected mice
is undiminished by anti-IL-10R antibody, while MLNC
from IL-10-deficient infected mice transfer suppression
of allergy into uninfected animals [17]. Hence, in the
mouse at least, IL-10 does not appear to be a primary
mechanism for helminth-associated Treg function.
TGF-b, however, remains a credible candidate for the
functional Treg product in this system, with respect to
both the induction and survival of Treg [63], and the
down-modulation of effector Tcell populations [64]. We
found significantly raised surface TGF-b staining over
the course of infection, and others have reported
parasite antigen-specific TGF-b release in similar
experiments [31]. Most recently, Doligalska and collea-
gues [65] have reported that anti-TGF-b antibody
treatment greatly reduces egg production and worm
survival in mice, indicating an important role for TGF-b
in parasite immune evasion. Interestingly, in our
experiments, increased TGF-b was observed within
the CD25+Foxp3– subset, and not among CD25+Foxp3+
cells. Hence, the cells induced to express TGF-b may be
adaptive Treg most similar to the Tr1/Th3 type
described in other systems, in particular the TGF-
b-secreting cells derived from theMLN of orally tolerised
mice [56].
Figure 7. CD103 and TGF-b expression is raised in frequency
and intensity by H. polygyrus infection. MLNC were stained for
CD4, CD25, CD103 and TGF-b and analysed by flow cytometry.
For CD103 and TGF-b, the percentages within total CD4+CD25+
T cell populations were calculated, as well as the percentage
change in MFI for each infected group compared to the
corresponding nave group; Mann–Whitney tests were per-
formed (n.s., no significant difference; *p<0.05, **p<0.01). Data
represent means  SE from groups of five mice assayed
individually. Day 0 represents all nave mice (five for each
time point). (A) CD103+ T cell numbers over the time course
(left), and as proportion of total CD4+CD25+ or CD4+CD25–
T cells in nave and day 28-infectedMLNC (right). Over the time
course, mean nave level = 18.3% (SD = 4.09). (B) CD103
expression levels over the time course (left) and in represen-
tative MLNC from nave (grey line) and day 28-infected (thick
black line)mice (right); isotype controls are shownas thin black
lines. (C) TGF-b+ cell numbers over the time course (left), and as
proportion of total CD4+CD25+ or CD4+CD25– T cells in nave
and day 28-infected MLNC (right). Over the time course, mean
nave level = 8.01% (SD = 2.67). (D) TGF-b expression levels over
the time course (left), and in representative MLNC from nave
(grey line) and day 28-infected (thick black line) mice (right);
isotype controls are shown as thin black lines.
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We also observed a marked increase in CTLA-4
expression among T cells from infected mice. CTLA-4 is
an inhibitory component of the co-stimulation machin-
ery associated with T cell receptor signalling, and may
act by competing for ligand with the CD28 stimulatory
receptor, and by raising the activation threshold of
T cells through the immunological synapse [66]. Hence,
when CTLA-4 is blocked by antibody treatment in vivo,
parasite expulsion is accelerated [67]. Interestingly, the
more substantial upshift in CTLA-4 staining was seen on
CD25– cells, and this change occurred later in the course
of infection than the expansion in CD25+ cell numbers.
It is plausible, therefore, that the CD25–CTLA-4+
phenotype represents an anergic effector cell, as
postulated in both human [48, 49] and mouse [6]
helminth infections, which develops subsequent to and
under the influence of the more rapidly arising Treg
response to infection.
GITR, originally identified as a marker up-regulated
onTreg, is a receptor thought to activate both regulatory
and effector cells on ligation. In H. polygyrus infection,
levels of GITR expression increase albeit less than
observed for CTLA-4. In particular, CD25– T cells as well
as Foxp3–CD25+ cells show small but significant uplifts
in the frequency of GITR expression. The induction of
GITR on the CD25– population is similar to that observed
in the tissue helminth infection, L. sigmodontis [6].
Tregmay act either, or both, at the induction stages of
the immune response and at the inflammatory phase in
the tissues. In H. polygyrus infections, priming to
allergens is unaffected and infection-generated Treg
transferred into fully primed mice suppress inflamma-
tion in the lung [17]. If infection-induced Treg act
primarily at the site of inflammation, this may be
reflected in the pattern of homing marker expression
[68, 69]. In this context, the marked up-regulation of
CD103 on the infected CD4+CD25+ T cell subset may
have particular functional significance. CD103 is a
homing marker and is expressed on 20–30% of Treg in
lymphoid organs [53]. CD103, therefore, may not be a
mechanistic mediator of suppression, but rather a pre-
requisite for Treg to traffic into, and remain at, sites of
inflammation. In a model of leishmaniasis, CD103 is
induced and maintained on Treg following or just prior
Figure 8. By day 28 of infection, CD103+Foxp3+ cells increase whilst TGFb+Foxp3+ do not. Cells were stained for CD4, CD25, CD103,
Foxp3 and TGF-b. Levels of CD103, TGF-b and Foxp3 expression were determined within the CD4+CD25+ population.
Mann–Whitney tests were performed (n.s., no significant difference; **p<0.01). (A) CD103 expression plotted by bivariate
analysis against Foxp3 staining, in nave and day 28-infected MLNC (left), and percentage expression of CD103+Foxp3+ and
CD103+Foxp3– cellswithinCD25+ T cell populations (right). (B) SurfaceTGF-b expression plotted by bivariate analysis against Foxp3
staining, in nave and day 28-infected MLNC (left), and percentage expression of TGF-b+Foxp3+ and TGF-b+Foxp3– cells within
CD25+ T cell populations (right).
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to their arrival in inflamed tissues [70]. Hence, CD103
does not define a lineage of CD25+ Treg with distinct
properties, but rather a subset capable of homing into
the site of infection. The expression of CD103 is
positively regulated by TGF-b [71]. Surface TGF-b levels
increase during infection, and this may provide a
mechanism by which CD103 is continuously up-
regulated.
In conclusion, we show here that H. polygyrus
induces significant phenotypic changes in distinct
subsets of cells, including one with functional suppres-
sive properties and some characteristic markers asso-
ciated with Treg. It may be significant that the Foxp3-
expressing population is only one of the players in the
system, and we cannot yet distinguish whether 'natural'
and 'adaptive' Treg expand independently in the context
of this infection, or the evolution of the adaptive
phenotype is dependent upon the pre-existing natural
Treg population. Further characterisation of these
regulatory cells, their antigen specificity and their
mechanisms is therefore imperative, as is the analysis
of the potentially anergic effector T cell population
which we have postulated. Nematode infections are of
particular importance since they affect over two billion
people worldwide, mostly in poverty-stricken regions
where numerous other infections are rife. Unravelling
the effects of dampened immune responses, due to
increased regulatory mechanisms triggered by worms,
on disease progression and outcome in co-infected
people would open new avenues for treatment, control
and eradication of these prevalent diseases.
Materials and methods
Mice and parasites
Female BALB/c mice, 6–8 wk of age and maintained in
individually ventilated cages, were infected with
200 H. polygyrus bakeri infective L3 larvae using a gavage
tube. In time-course experiments, a matched group of nave
animals was analysed at each time point taken.
H. polygyrus antigen and ELISA
H. polygyrus antigen was prepared by homogenising adult
worms in PBS, which was centrifuged (13 000  g, 10 min);
the supernatant was filtered (0.2 lm Millex) and stored at
1.5 mg/mL at –80C. Antigen-specific antibody responses were
determined by ELISA. Multisorp (Nunc) plates were coated
with 5 lg/mL H. polygyrus antigen in 0.06 M carbonate buffer
pH 9.6, overnight at 4C. Plates were blocked with 5% BSA
(fraction V, Gibco) for 2 h at 37C. Sera were diluted in TBS/
0.05% Tween and added to wells overnight at 4C. Antigen-
specific IgG isotypes were detected with HRP-conjugated goat
anti-mouse IgG1 (1070-05, Southern Biotechnology) and anti-
IgG2a (1080-05), with ABTS peroxidase substrate (50-62-00,
KPL).
In vitro restimulation and cytokine assays
Unfractionated LN and spleen cells were cultured at 1107/mL
in 96-well plates (3799, Costar) for 48 h in RPMI 1640
medium (Gibco), 10% FCS, 1% L-glutamine, 1% penicillin/
streptomycin (supplemented RPMI 1640) in the presence of
10 lg/mL H. polygyrus antigen or 1 lg/mL Con A (Sigma).
Cytokines in supernatants were measured by ELISA according
to suppliers' guidelines. Capture antibodies for IL-4 (11B11,
4 lg/mL), IL-5 (TRFK5, 2 lg/mL), IL-10 (JES5-2A5, 4 lg/mL)
and IFN-c (R46A2, 3 lg/mL) were produced in-house or by
Pharmingen. Capture antibody for IL-13 (38213, 2 lg/mL)
was from R&D Systems, and that for IL-9 (229.4, 5 lg/mL)
kindly provided by Dr. Melanie Leech (IIIR, Edinburgh).
Biotinylated detection antibodies were from Pharmingen: IL-4
(BVD6-24G2, 5 lg/mL), IL-5 (TRFK4, 2 lg/mL), IL-9
(D9302C12, 1 lg/mL), IL-10 (SXC-1, 2 lg/mL) and IFN-c
(XMG1.2, 0.5 lg/mL), or for IL-13, from Peprotech (rabbit
polyclonal, cat. No. 500-P178Bt, 0.1 lg/mL).
Flow cytometry
LN and spleen cell suspensions were prepared for flow
cytometry at 1107/mL in supplemented RPMI 1640. Anti-
bodies were diluted in PBS, 0.5% BSA (Sigma), 0.05% sodium
azide, and added to cell suspensions (1106–2106 total cells)
for 20 min at 4C. For detection of CD4+CD25+ and
CD4+CD25– cells, rat anti-mouse CD4 (L3T4, clone RM4-5,
IgG2a, 1/100) and anti-CD25 (clone PC61, IgG1, CALTAG, 1/
100) monoclonal antibodies were used. For intracellular IL-10
and CTLA-4 staining, cells were permeablised in cytofix/
cytoperm, washed in perm/wash buffer (Pharmingen) and
stained with rat anti-mouse IL-10 (JES5-16E3, rat IgG2b,1/50)
or CTLA-4 (UC10-4F10-11, 1/10) for 30 min. For staining
Foxp3, cells were permeablised in cytofix/cytoperm for 1 h,
washed in perm/wash buffer (eBiosciences) and stained with
rat anti-mouse Foxp3 (FJK-16s, rat IgG2a, eBiosciences, 1/50)
for 30 min. Surface-bound TGF-b, CD103 and GITR were
detected using rat anti-mouse TGF-b1 (A75-3, IgG2a, 1/25),
CD103 (M290, IgG2a, 1/100) and GITR (DTA-1, IgG2a,
produced in-house, 1/250). Analysis was performed on an
LSR II flow cytometer using FlowJo software (Tree Star). All
fluorochrome-labeled antibodies were obtained from BD
Pharmingen, unless otherwise stated.
CD4+ T cell enrichment and quantitative PCR
For CD4+ cell purification, cell suspensions were incubated at
1108/mL with 10 lL CD4 (L3T4) microbeads (130-049-201,
Miltenyi Biotech) per 107 cells and separated on MACS MS
columns with pre-separation filters. RNA was recovered from
purified CD4+ cells by the addition of Trizol (Invitrogen, 1 mL/
106 cells), and extracted following themanufacturer's protocol.
RT-PCR was performed with 1 lg RNA using murine Moloney
leukaemia virus reverse transcriptase (Stratagene) and
oligo(dT) primers (Promega). Transcript quantification was
performed by real-time RT-PCR, using the LightCycler (Roche
Molecular Biochemicals), with b-actin for normalisation.
PCR amplifications were in 10 lL, containing 1 lL cDNA,
1.2 lL MgCl2 (25 mM), 0.3 lL (10 lM) primers and 1 lL
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LightCycler-DNA SYBRGreen-I mix (10). For Foxp3 amplifi-
cation the QuantiTech SYBRGreen PCR Kit (Qiagen) was used,
and PCR amplifications were performed in 10 lL, containing
1 lL cDNA, 0.5 lL (10 lM) primers and 5 lL SYBRGreen mix.
The amplification of b-actin (50-TGGAATCCTGTGGCATCCAT-
GAAAC-30, 50-TAAAACGCAGCTCAGTAACAGTCCG-30), T-bet
(50-GCCAGGGAACCGCTTATATG-30, 50-GACGATCATCTGGG-
TCACATTGT-30), Smad-7 (50-GCATTCCTCGGAAGTCAAG-
AGG-30, 50-TGCGGTTGTAAACCCACACG-30), Foxp3 (50-CCT-
GGCCTGCCACCTGGGATCAA-30, 50-TTCTCACAACCAGGC-
CACTTG-30) and Gata-3 (50-CTACGGTGCAGAGGTATCC-30,
50-GATGGACGTCTTGGAGAAGG-30) was performed as fol-
lows: 30 s denaturation at 95C, 5 s annealing at 55C and 12 s
elongation at 72C, for 40–60 cycles. For T-bet the acquisition
temperature was reduced to 84C. Conventional curve
analyses were performed according to the LightCycler
instruction kit. Products were run on agarose to ensure that
no genomic DNA amplification occurred.
CD25 enrichment and suppression assay
For CD4+CD25+ cell enrichment, CD4+ cells were negatively
isolated using sheep anti-rat IgG beads (M540, Dynal) and
biotinylatedanti-MAC1(0.5 lL/107 cells,M1/70.15),anti-CD8a
(0.5 lL/107 cells, 53-6.72), anti-MHC class II (1 lL/107 cells,
M5114), anti-B220 (0.5 lL/107 cells, RAB632) and anti-GR1
(3.33 lL/107 cells, RB6-8C5,BDPharmingen).Antibody-bound
beads and cell solutions were separated on a magnetic particle
concentrator(DynalMPC).PositiveselectionofCD25+cells then
employed PE-conjugated anti-CD25 (130-091-013, Miltenyi
Biotech)andPEmicrobeads (130-048-801,MiltenyiBiotech), on
MACS LS separation columns with pre-separation filters. CD25–
cells obtained were stained with CFSE (5 lM, Sigma) and
culturedwith or without 5104CD4+CD25+ cells for 4 days in a
1:1 ratio,with 1105 irradiatedCD4–APCand in thepresenceof
1 lg/mL Con A.
Statistics
Mann–Whitney test was used for all statistical comparisons;
p values less than 0.05 were considered significant. To
compare the percentage of cells positive for the surface and
intracellular markers studied, the difference in frequency of
the marker was calculated between each infected group and its
nave group. For comparing intensity levels, the difference in
each infected group compared to its nave group was
calculated as a percentage increase/decrease compared to
the baseline nave values.
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